SCHEMBL21703346

SCHEMBL21703346

CC(O)CNC(=O)C1CCC(F)(F)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.39
DRD2 P14416 3/20 0.39
DRD4 P21917 3/20 0.39
KCNH2 Q12809 3/20 0.39
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.38
ALOX15 P16050 1/20 0.38
KMT2A Q03164 1/20 0.38
PSMB5 P28074 3/20 0.37
ITGB3 P05106 1/20 0.37
ITGA2B P08514 1/20 0.37
MTNR1A P48039 3/20 0.37
MTNR1B P49286 3/20 0.37
EPHX2 P34913 3/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
WNT1 P04628 1/20 0.35
GSK3B P49841 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5858399 0.80 EPHX1 (0.53) MEN1KMT2APSMB5SMN1; SMN2HSD17B10
SCHEMBL7929143 0.77 CHRNB2 (0.39) HTR1ADRD2DRD4KCNH2ALDH1A1
SCHEMBL13451484 0.77 GNAI3 (0.51) MEN1NPC1ALDH1A1TP53ALOX15
SCHEMBL22231128 0.77 CTH (0.40) HTR1ADRD2DRD4KCNH2KMT2A
SCHEMBL31139892 0.77 GNAI3 (0.51) MEN1NPC1ALDH1A1TP53ALOX15
SCHEMBL23733300 0.76 KCNH2 (0.39) HTR1ADRD2DRD4KCNH2KMT2A
SCHEMBL2576718 0.76 MTNR1A (0.46) MEN1NPC1ALDH1A1TP53ALOX15
SCHEMBL2576721 0.76 MTNR1A (0.46) MEN1NPC1ALDH1A1TP53ALOX15
SCHEMBL2369715 0.76 HTR1A (0.39) HTR1ADRD2DRD4KCNH2MEN1
SCHEMBL28271183 0.75 KCNH2 (0.43) HTR1ADRD2DRD4KCNH2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020033784-A1 TRANSGLUTAMINASE 2 (TG2) INHIBITORS SITARI PHARMA, INC. (US) 2020-02-13 WO disclosed